NASDAQ:TRHCTabula Rasa HealthCare Stock Price, Forecast & News

$55.44

+1.86 (+3.47 %)

(As of 06/2/2020 10:11 AM ET)

Add

Compare

Today's Range

$53.58

Now: $55.44▼

$55.64

50-Day Range

$53.07

MA: $58.70▼

$64.33

52-Week Range

$33.04

Now: $55.44▼

$69.72

Volume1,938 shs

Average Volume354,405 shs

Market Capitalization$1.28 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.17

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. The company's cloud-based software applications also comprise RxCompanion, a medication therapy management software platform for the identification and resolution of medication and other health related problems; TruChart, an electronic health record (EHR) system for Programs of All-Inclusive Care for the Elderly (PACE) programs; and PACElogic, which deliver real-time sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination, planning, integration with community-based providers, and various Federal and State required reporting for PACE organizations and small health plans. Tabula Rasa HealthCare, Inc. also offers clinical pharmacist collaboration, prescription fulfillment and reminder packaging, and pharmacy cost management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2018, it served 224 healthcare organizations. The company offers its cloud-based software solutions to prescribers, pharmacists, and healthcare organizations for managing the medication-related needs of their patients. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Beat the Market (BTM) Rank^™

3.4 Analyst's Opinion

Consensus Rating
Tabula Rasa HealthCare has received a consensus rating of Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $71.67, Tabula Rasa HealthCare has a potential upside of 29.3% from its current price of $55.44.
Amount of Analyst Coverage
Tabula Rasa HealthCare has only been the subject of 3 research reports in the past 90 days.

2.6 Community Rank

Outperform Votes
Tabula Rasa HealthCare has received 306 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Tabula Rasa HealthCare has received 287 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Tabula Rasa HealthCare has received 51.60% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote “Outperform” if you believe TRHC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Tabula Rasa HealthCare does not currently pay a dividend.
Dividend Growth
Tabula Rasa HealthCare does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Tabula Rasa HealthCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,077,109.00 in company stock.
Percentage Held by Insiders
Only 11.60% of the stock of Tabula Rasa HealthCare is held by insiders.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Tabula Rasa HealthCare are expected to grow in the coming year, from ($0.31) to ($0.17) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Tabula Rasa HealthCare is -32.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Tabula Rasa HealthCare is -32.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Tabula Rasa HealthCare has a P/B Ratio of 6.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.33 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Business services, not elsewhere classified

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:TRHC

Previous Symbol

CUSIPN/A

CIK1651561

Webwww.tabularasahealthcare.com

Phone866-648-2767

Debt

Debt-to-Equity Ratio1.40

Current Ratio2.32

Quick Ratio2.20

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$284.71 million

Price / Sales4.48

Cash Flow$1.95 per share

Price / Cash Flow28.45

Book Value$8.36 per share

Price / Book6.63

Profitability

EPS (Most Recent Fiscal Year)($0.25)

Net Income$-32,440,000.00

Net Margins-12.10%

Return on Equity-3.01%

Return on Assets-1.11%

Miscellaneous

Employees1,286

Outstanding Shares23,020,000

Market Cap$1.28 billion

Next Earnings Date8/13/2020 (Estimated)

OptionableOptionable

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

How has Tabula Rasa HealthCare's stock been impacted by COVID-19 (Coronavirus)?

Tabula Rasa HealthCare's stock was trading at $45.88 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TRHC stock has increased by 20.8% and is now trading at $55.44. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Tabula Rasa HealthCare?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Tabula Rasa HealthCare.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Tabula Rasa HealthCare.

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) released its earnings results on Thursday, May, 7th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.24. The company had revenue of $72.80 million for the quarter, compared to analyst estimates of $71.76 million. Tabula Rasa HealthCare had a negative return on equity of 3.01% and a negative net margin of 12.10%. Tabula Rasa HealthCare's quarterly revenue was up 19.3% compared to the same quarter last year. During the same period in the previous year, the company posted $0.10 earnings per share. View Tabula Rasa HealthCare's earnings history.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its second quarter 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $76-81 million, compared to the consensus revenue estimate of $84.66 million.

What price target have analysts set for TRHC?

9 Wall Street analysts have issued 12 month price objectives for Tabula Rasa HealthCare's stock. Their forecasts range from $50.00 to $85.00. On average, they expect Tabula Rasa HealthCare's stock price to reach $71.67 in the next twelve months. This suggests a possible upside of 29.3% from the stock's current price. View analysts' price targets for Tabula Rasa HealthCare.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

News headlines about TRHC stock have trended very positive on Tuesday, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a media sentiment score of 3.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutTabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

Some companies that are related to Tabula Rasa HealthCare include CDK Global (CDK), Farfetch (FTCH), Ritchie Bros. Auctioneers (RBA), MAXIMUS (MMS), Healthequity (HQY), Envestnet (ENV), TriNet Group (TNET), Stamps.com (STMP), HMS (HMSY), WNS (WNS), Alliance Data Systems (ADS), Fiverr International (FVRR), ExlService (EXLS), Wageworks (WAGE) and CIELO S A/S (CIOXY). View all competitors.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Canopy Growth (CGC), Netflix (NFLX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), salesforce.com (CRM), Boeing (BA), GW Pharmaceuticals PLC- (GWPH) and Intel (INTC).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the following people:

Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
Mr. Brian W. Adams, CFO & Sec. (Age 37)
Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.14%), Bank of New York Mellon Corp (3.21%), Ranger Investment Management L.P. (3.00%), William Blair Investment Management LLC (2.77%), State Street Corp (2.70%) and Wasatch Advisors Inc. (2.13%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, Orsula V Knowlton and Samira Beckwith. View institutional ownership trends for Tabula Rasa HealthCare.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Waddell & Reed Financial Inc., KBC Group NV, CWM LLC, Wellington Management Group LLP, BlackRock Inc., Handelsbanken Fonder AB, and Peregrine Capital Management LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Michael Greenhalgh, and Orsula V Knowlton. View insider buying and selling activity for Tabula Rasa HealthCare.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Fred Alger Management LLC, AXA, William Blair Investment Management LLC, State Street Corp, Emerald Mutual Fund Advisers Trust, New York State Common Retirement Fund, and Geode Capital Management LLC. View insider buying and selling activity for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $55.44.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.28 billion and generates $284.71 million in revenue each year. The company earns $-32,440,000.00 in net income (profit) each year or ($0.25) on an earnings per share basis. Tabula Rasa HealthCare employs 1,286 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff